Component

SELENOK

An endoplasmic-reticulum membrane selenoprotein represented independently from selenium and ZDHHC6.

9 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Loss of SELENOK removes the cofactor support described for the ZDHHC6 palmitoyl acyl-enzyme intermediate.

    SELENOK → ZDHHC6 source_derived_draftsource_reported: Animal knockout and cell/biochemical mechanism reported by an unverified supplied draft.
    Experimental context and source evidence
    availability_state
    Insufficient or absent SELENOK function; the reported phenotype comes from SELENOK-null mice.
    experimental_scope
    SELENOK loss-of-function animal model and supplied biochemical mechanism, including T-cell context.
    limitations
    Dietary selenium restriction is not proven equivalent to SELENOK knockout. No selenium concentration is mapped to this phenotype, and this scenario does not invert every downstream normal-path arrow.
    trigger_kind
    machinery_impairment

    Selenium in immune cells · lines 18–20

    Selenium immune-cell mechanism draft · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    2. SELENOK binds ZDHHC6 (ER palmitoyl-S-acyltransferase, DHHC motif) → SELENOK is required as a COFACTOR to stabilize the palmitoyl-ZDHHC6 acyl-enzyme intermediate

    Selenium: the molecular cascade · lines 139–139

    Selenium molecular cascade draft · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    **SELENOK** — not a peroxidase. It's the essential cofactor for **ZDHHC6**, the palmitoyl transferase. No SELENOK → failed palmitoylation of IP3R, calnexin, and others → broken Ca²⁺ flux in T cells. **Selenium regulating lipid post-translational modification.**
    Complete structured claim and evidence
  2. The supplied draft reports failed IP3R palmitoylation when SELENOK is absent.

    SELENOK → IP3R source_derived_draftsource_reported: Animal knockout and cell/biochemical mechanism reported by an unverified supplied draft.
    Experimental context and source evidence
    availability_state
    Insufficient or absent SELENOK function; the reported phenotype comes from SELENOK-null mice.
    experimental_scope
    SELENOK loss-of-function animal model and supplied biochemical mechanism, including T-cell context.
    limitations
    Dietary selenium restriction is not proven equivalent to SELENOK knockout. No selenium concentration is mapped to this phenotype, and this scenario does not invert every downstream normal-path arrow.
    trigger_kind
    machinery_impairment

    Selenium in immune cells · lines 22–28

    Selenium immune-cell mechanism draft · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    3. ZDHHC6 palmitoylates: • IP3R (all three isoforms) • calnexin • itself (autopalmitoylation) 4. Palmitoylated IP3R = stable, correctly localized, functional channel Non-palmitoylated IP3R = degraded / non-functional

    Selenium: the molecular cascade · lines 139–139

    Selenium molecular cascade draft · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    **SELENOK** — not a peroxidase. It's the essential cofactor for **ZDHHC6**, the palmitoyl transferase. No SELENOK → failed palmitoylation of IP3R, calnexin, and others → broken Ca²⁺ flux in T cells. **Selenium regulating lipid post-translational modification.**
    Complete structured claim and evidence
  3. SELENOK-null mice show blunted immune-cell calcium flux in the source-described IP3R-dependent ER calcium-release pathway.

    SELENOK → ER calcium release source_derived_draftsource_reported: Animal knockout and cell/biochemical mechanism reported by an unverified supplied draft.
    Experimental context and source evidence
    availability_state
    Insufficient or absent SELENOK function; the reported phenotype comes from SELENOK-null mice.
    experimental_scope
    SELENOK loss-of-function animal model and supplied biochemical mechanism, including T-cell context.
    limitations
    Dietary selenium restriction is not proven equivalent to SELENOK knockout. No selenium concentration is mapped to this phenotype, and this scenario does not invert every downstream normal-path arrow.
    trigger_kind
    machinery_impairment

    Selenium in immune cells · lines 27–32

    Selenium immune-cell mechanism draft · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    4. Palmitoylated IP3R = stable, correctly localized, functional channel Non-palmitoylated IP3R = degraded / non-functional 5. TCR → LCK → ZAP70 → LAT → PLCγ1 → PIP₂ → IP₃ + DAG 6. IP₃ → IP3R → ER Ca²⁺ release → store depletion

    Selenium in immune cells · lines 42–42

    Selenium immune-cell mechanism draft · supports · Supplied reference; verify the primary study and experimental context. · source_derived_draft · unverified_draft

    **Kill SELENOK and you lose step 4.** The phenotype in SELENOK⁻/⁻ mice is exactly what the chain predicts: blunted Ca²⁺ flux in **T cells, B cells, neutrophils, and macrophages**; reduced TCR-driven proliferation; impaired chemotaxis; reduced IL-2.
    Complete structured claim and evidence
  4. SELENOK and DHHC6 interacted at the ER membrane through SH3-related binding interactions.

    SELENOK → ZDHHC6 source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/25368151.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9", "start_char": 0, "end_char": 1873, "text_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9"}
    experimental_model
    Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays
    exposure
    Selk deletion, low-selenium media, DHHC6 knockdown and IP3R cysteine mutants
    limitations
    Selenium limitation and genetic deletion are distinct. This does not establish that inositol supplements repair selenium-dependent receptor failure.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Mouse immune cells and mammalian cell models
    plain_language
    Two separately identifiable proteins cooperate in maintaining the receptor.
    primary_references
    [ino-p25368151] Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. (2014). https://pubmed.ncbi.nlm.nih.gov/25368151/ DOI: 10.1073/pnas.1417176111
    tissue_or_cell_type
    ER-associated IP3 receptor machinery

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1094–1105

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays · source_derived_draft · unverified_draft

    ### ino-selk-dhhc6 SELENOK and DHHC6 interacted at the ER membrane through SH3-related binding interactions. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: Two separately identifiable proteins cooperate in maintaining the receptor. organism: Mouse immune cells and mammalian cell models tissue_or_cell_type: ER-associated IP3 receptor machinery experimental_model: Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays limitations: Selenium limitation and genetic deletion are distinct. This does not establish that inositol supplements repair selenium-dependent receptor failure. exposure: Selk deletion, low-selenium media, DHHC6 knockdown and IP3R cysteine mutants evidence_span: {"source_cache": "artifacts/inositol-research/25368151.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9", "start_char": 0, "end_char": 1873, "text_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9"} [ino-p25368151] Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. (2014). https://pubmed.ncbi.nlm.nih.gov/25368151/ DOI: 10.1073/pnas.1417176111
    Complete structured claim and evidence
  5. SELENOK deficiency did not impair receptor-induced IP3 production in the reported experiments.

    SELENOK → Receptor-evoked IP3 production source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/inositol-research/25368151.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9", "start_char": 0, "end_char": 1873, "text_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9"}
    experimental_model
    Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays
    exposure
    Selk deletion, low-selenium media, DHHC6 knockdown and IP3R cysteine mutants
    limitations
    Selenium limitation and genetic deletion are distinct. This does not establish that inositol supplements repair selenium-dependent receptor failure.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Mouse immune cells and mammalian cell models
    plain_language
    Failure downstream of IP3 does not automatically mean too little inositol or too little IP3.
    primary_references
    [ino-p25368151] Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. (2014). https://pubmed.ncbi.nlm.nih.gov/25368151/ DOI: 10.1073/pnas.1417176111
    tissue_or_cell_type
    ER-associated IP3 receptor machinery
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1081–1092

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays · source_derived_draft · unverified_draft

    ### ino-selk-message-intact SELENOK deficiency did not impair receptor-induced IP3 production in the reported experiments. Condition category: machinery_impairment nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: Failure downstream of IP3 does not automatically mean too little inositol or too little IP3. organism: Mouse immune cells and mammalian cell models tissue_or_cell_type: ER-associated IP3 receptor machinery experimental_model: Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays limitations: Selenium limitation and genetic deletion are distinct. This does not establish that inositol supplements repair selenium-dependent receptor failure. exposure: Selk deletion, low-selenium media, DHHC6 knockdown and IP3R cysteine mutants evidence_span: {"source_cache": "artifacts/inositol-research/25368151.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9", "start_char": 0, "end_char": 1873, "text_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9"} [ino-p25368151] Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. (2014). https://pubmed.ncbi.nlm.nih.gov/25368151/ DOI: 10.1073/pnas.1417176111
    Complete structured claim and evidence
  6. SELENOI, GPX4, and SELENOK may converge on phosphatidylethanolamine synthesis, protection, and calcium-linked peroxidation control.

    SELENOK → Phosphatidylethanolamine hypothesisunverified_cross_path_inference
    Experimental context and source evidence

    Selenium corrections and deep dive · lines 446–448

    Selenium correction and deep-dive draft · supports · Source draft; model details require primary-source verification · source_derived_draft · unverified_draft

    **4. The PE circuit.** SELENOI **makes** PE. GPX4 **protects** PE. SELENOK **enables palmitoylation of IP3R**, which controls the Ca²⁺ flux that drives lipid peroxidation. Three selenoproteins, three different verbs, one lipid. SELENOI mutations cause **SPG81 spastic paraplegia**; GPX4 loss causes **interneuron death**. Both neurological, both PE. Nobody has assayed them as one circuit. **If I were hunting for something undiscovered, this is where I'd put the money.**
    Complete structured claim and evidence
  7. SELENOK supports ZDHHC6 by stabilizing the palmitoyl-ZDHHC6 acyl-enzyme intermediate.

    SELENOK → ZDHHC6 source_derived_draftsupplied_source_only
    Experimental context and source evidence
    cell_type
    · T cell
    evidence_scope
    Source-derived draft; primary-source verification required
    organism
    · Human

    Selenium in immune cells · lines 11–20

    Selenium immune-cell mechanism draft · supports · Source draft; model details require primary-source verification · source_derived_draft · unverified_draft

    # I. THE CLEANEST CHAIN — SELENOK → Ca²⁺ → NFAT → IL-2 This is the one to memorize. It's a direct, non-redox, molecule-by-molecule path from a selenium atom to a cytokine. ``` 1. Se → Sec-tRNA → SELENOK (ER membrane, single C-terminal Sec, tail in cytosol) 2. SELENOK binds ZDHHC6 (ER palmitoyl-S-acyltransferase, DHHC motif) → SELENOK is required as a COFACTOR to stabilize the palmitoyl-ZDHHC6 acyl-enzyme intermediate

    Selenium: the molecular cascade · lines 135–143

    Selenium molecular cascade draft · supports · Source draft; model details require primary-source verification · source_derived_draft · unverified_draft

    **SELENOO** — the strangest protein in the set. Its bacterial ortholog **SelO** looks exactly like a protein kinase but binds ATP **flipped backwards** in the pocket, so it transfers **AMP instead of phosphate**. It's an **AMPylase**, activated by oxidative stress, AMPylating GAPDH and other redox enzymes. A pseudokinase that runs in reverse. Human SELENOO is mitochondrial and largely uncharacterized. **MSRB1 (SELENOR)** — redox control of the cytoskeleton. **MICAL1/2** oxidizes actin **Met44 and Met47** to the R-sulfoxide → actin depolymerizes. MSRB1 reduces it back → repolymerization. In macrophages this gates phagocytic cup formation. **Selenium is a direct rheostat on actin dynamics.** Almost nobody knows this. **SELENOK** — not a peroxidase. It's the essential cofactor for **ZDHHC6**, the palmitoyl transferase. No SELENOK → failed palmitoylation of IP3R, calnexin, and others → broken Ca²⁺ flux in T cells. **Selenium regulating lipid post-translational modification.** **SELENOI (EPT1)** — the only selenoprotein with **zero redox function**. It's an ethanolamine phosphotransferase making phosphatidylethanolamine. Mutations → hereditary spastic paraplegia **SPG81**. (And PE is exactly the lipid GPX4 protects. There's a loop there worth pulling on.) **SELENON** — ER membrane, regulates **RyR1** redox state and SERCA2b. Mutations → SEPN1-related myopathy / rigid spine syndrome.
    Complete structured claim and evidence

What acts on it

  1. Sec-tRNA enables translation of SELENOK.

    Sec-tRNA[Ser]Sec → SELENOK source_derived_draftsupplied_source_only
    Experimental context and source evidence
    cell_type
    · T cell
    evidence_scope
    Source-derived draft; primary-source verification required
    organism
    · Human

    Selenium in immune cells · lines 11–20

    Selenium immune-cell mechanism draft · supports · Source draft; model details require primary-source verification · source_derived_draft · unverified_draft

    # I. THE CLEANEST CHAIN — SELENOK → Ca²⁺ → NFAT → IL-2 This is the one to memorize. It's a direct, non-redox, molecule-by-molecule path from a selenium atom to a cytokine. ``` 1. Se → Sec-tRNA → SELENOK (ER membrane, single C-terminal Sec, tail in cytosol) 2. SELENOK binds ZDHHC6 (ER palmitoyl-S-acyltransferase, DHHC motif) → SELENOK is required as a COFACTOR to stabilize the palmitoyl-ZDHHC6 acyl-enzyme intermediate
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Low-selenium culture conditions were associated with defective IP3R palmitoylation and reduced receptor expression in the SELENOK study.

    Selenium → IP3 receptor palmitoylation source_derived_draftungraded
    Experimental context and source evidence
    availability_state
    nutrient_deficiency Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/inositol-research/25368151.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9", "start_char": 0, "end_char": 1873, "text_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9"}
    experimental_model
    Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays
    exposure
    Selk deletion, low-selenium media, DHHC6 knockdown and IP3R cysteine mutants
    limitations
    Selenium limitation and genetic deletion are distinct. This does not establish that inositol supplements repair selenium-dependent receptor failure.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Mouse immune cells and mammalian cell models
    plain_language
    The cell may still make the message but lose a properly maintained receptor.
    primary_references
    [ino-p25368151] Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. (2014). https://pubmed.ncbi.nlm.nih.gov/25368151/ DOI: 10.1073/pnas.1417176111
    tissue_or_cell_type
    ER-associated IP3 receptor machinery
    trigger_kind
    nutrient_deficiency Imported condition classification; unverified.

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 1068–1079

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays · source_derived_draft · unverified_draft

    ### ino-selenium-receptor Low-selenium culture conditions were associated with defective IP3R palmitoylation and reduced receptor expression in the SELENOK study. Condition category: nutrient_deficiency nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cell may still make the message but lose a properly maintained receptor. organism: Mouse immune cells and mammalian cell models tissue_or_cell_type: ER-associated IP3 receptor machinery experimental_model: Immune-cell perturbation, co-immunoprecipitation and palmitoylation assays limitations: Selenium limitation and genetic deletion are distinct. This does not establish that inositol supplements repair selenium-dependent receptor failure. exposure: Selk deletion, low-selenium media, DHHC6 knockdown and IP3R cysteine mutants evidence_span: {"source_cache": "artifacts/inositol-research/25368151.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9", "start_char": 0, "end_char": 1873, "text_sha256": "84452ee9a1f04bf54aba8030e5384d46a1dafdbb460281fd99c244e57d6644d9"} [ino-p25368151] Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. (2014). https://pubmed.ncbi.nlm.nih.gov/25368151/ DOI: 10.1073/pnas.1417176111
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards